1. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial. (January 2022) Authors: Hill, Louise F; Clements, Michelle N; Turner, Mark A; Donà, Daniele; Lutsar, Irja; Jacqz-Aigrain, Evelyne; Heath, Paul T; Roilides, Emmanuel; Rawcliffe, Louise; Alonso-Diaz, Clara; Baraldi, Eugenio; Dotta, Andrea; Ilmoja, Mari-Liis; Mahaveer, Ajit; Metsvaht, Tuuli; Mitsiakos, George; Papaevangelo... Journal: Lancet Issue: Volume 6:Number 1(2022) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗